Answers are grounded in this paper and cite their sources.
We propose ppGalNAc-T13 as a new informative marker for the molecular diagnosis of BM involvement and the follow-up of minimal residual disease in NB patients.
No takes yet. Share an insight, caveat, or question.
Berois et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: